CN101843717B - Chinese medicament for treating coronary disease - Google Patents
Chinese medicament for treating coronary disease Download PDFInfo
- Publication number
- CN101843717B CN101843717B CN200910236179XA CN200910236179A CN101843717B CN 101843717 B CN101843717 B CN 101843717B CN 200910236179X A CN200910236179X A CN 200910236179XA CN 200910236179 A CN200910236179 A CN 200910236179A CN 101843717 B CN101843717 B CN 101843717B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- parts
- chinese
- radix
- fine powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 27
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 12
- 241000218176 Corydalis Species 0.000 claims abstract description 12
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 241000722953 Akebia Species 0.000 claims abstract 2
- 239000000843 powder Substances 0.000 claims description 17
- 239000002775 capsule Substances 0.000 claims description 16
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 10
- 241000180649 Panax notoginseng Species 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 6
- 210000004369 blood Anatomy 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract description 2
- 230000003213 activating effect Effects 0.000 abstract 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 235000017965 Asarum canadense Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000000385 Costus speciosus Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241000606265 Valeriana jatamansi Species 0.000 abstract 1
- 235000014687 Zingiber zerumbet Nutrition 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 206010040007 Sense of oppression Diseases 0.000 description 4
- 241000207961 Sesamum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- AXONCVPTTFHNOI-UHFFFAOYSA-N kairine Chemical compound C1=CC(O)=C2N(C)CCCC2=C1 AXONCVPTTFHNOI-UHFFFAOYSA-N 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010049119 Emotional distress Diseases 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 230000009429 distress Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000000088 lip Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Abstract
The invention relates to a Chinese medicament for treating a coronary disease, and belongs to the field of Chinese medicaments for treating cardio-cerebral-vascular system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: manchurian wildginger, Chinese angelica, root of rehmannia, cassia twig, lucid ganoderma, rhizoma corydalis, akebia stem, radix pseudo-ginseng and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, and activating yang and relieving pain, and has the advantages of obvious effect, exact medicinal effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of cardiovascular and cerebrovascular systems.
Background technology
Be intended to treat the field of Chinese medicines of coronary heart disease at present, have the deficiency of two aspects: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.Many patients with coronary heart disease are stood the torment of feeling of oppression and pain in the chest for a long time, face the danger of myocardial infarction, and patient and family members thereof are satisfied inadequately to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of coronary heart disease, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
A kind of Chinese medicine for the treatment of coronary heart disease adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Herba Asari 2-15 part Radix Angelicae Sinensis 4-30 part Radix Rehmanniae 4-30 part
Ramulus Cinnamomi 3-20 part Ganoderma 2-15 part Rhizoma Corydalis 3-20 part
Caulis Akebiae 3-20 part Radix Notoginseng 3-20 part
The Chinese medicine of this treatment coronary heart disease is made by following method:
(1) by above-mentioned weight ratio, Herba Asari, Radix Angelicae Sinensis, the Radix Rehmanniae, Ramulus Cinnamomi, Rhizoma Corydalis, Caulis Akebiae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Rehmanniae benefiting QI and nourishing blood in the side, the body resistance strengthening and constitution consolidating; Ramulus Cinnamomi, Herba Asari temperature cold expelling heresy, pain relieving activates yang; Radix Angelicae Sinensis, pseudo-ginseng blood-circulation-invigovating blood-activating analgetic; Be aided with Caulis Akebiae and go into, add that Rhizoma Corydalis is invigorated blood circulation, regulated the flow of vital energy, pain relieving through collateral dredging.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the merit of the pain relieving that activates yang, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Herba Asari 30 gram Radix Angelicae Sinensis 70 gram Radix Rehmanniae 70 grams
Ramulus Cinnamomi 50 kairine sesames 30 gram Rhizoma Corydalis 50 grams
Caulis Akebiae 50 gram Radix Notoginseng 50 grams
Weight in accordance with regulations, with conventional water extraction process Herba Asari, Radix Angelicae Sinensis, the Radix Rehmanniae, Ramulus Cinnamomi, Rhizoma Corydalis, Caulis Akebiae are extracted, make extractum fine powder 96 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 628 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
The Herba Asari 70 gram Radix Angelicae Sinensis 150 gram Radix Rehmanniae 150 grams
Ramulus Cinnamomi 100 kairine sesames 70 gram Rhizoma Corydalis 150 grams
Caulis Akebiae 100 gram Radix Notoginseng 150 grams
By above-mentioned same method, make 1557 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
The Herba Asari 150 gram Radix Angelicae Sinensis 300 gram Radix Rehmanniae 300 grams
Ramulus Cinnamomi 200 kairine sesames 150 gram Rhizoma Corydalis 200 grams
Caulis Akebiae 200 gram Radix Notoginseng 200 grams
By above-mentioned same method, make 2696 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
7 parts in 7 parts of Radix Rehmanniae of 4 parts of Radix Angelicae Sinensis of Herba Asari
6 parts of 4 parts of Rhizoma Corydalis of 6 portions of Ganodermas of Ramulus Cinnamomi
5 parts of 6 portions of Radix Notoginseng of Caulis Akebiae
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
25 parts in 25 parts of Radix Rehmanniae of 12 parts of Radix Angelicae Sinensis of Herba Asari
18 parts of 12 parts of Rhizoma Corydalis of 18 portions of Ganodermas of Ramulus Cinnamomi
18 parts of 18 portions of Radix Notoginseng of Caulis Akebiae
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science coronary heart disease, through 11 routine clinical observations.Selecting tcm diagnosis coronary heart disease is standard: have a delicate constitution, limb is soft weak, and feeling of oppression and pain in the chest is dizzy nervous, the Electrocardioscopy myocardial ischemia.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 6 examples, women's 5 examples do not have other serious disease, and the age is 42 years old-76 years old, 57.1 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, and on one's body energetically, cardiac distresses such as feeling of oppression and pain in the chest are obviously alleviated, and the visible blood supply of cardiac muscle of electrocardiogram obviously improves.
2, effective: body constitution strengthens, and cardiac distresses such as feeling of oppression and pain in the chest are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom is obviously improved.11 philtrums of clinical experiment, produce effects 5 people, effective 5 people, invalid 1 people, total effective rate 91.6%.
Claims (1)
1. a Chinese medicine for the treatment of coronary heart disease is characterized in that, described Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Herba Asari 2---30 parts of 15 parts of Radix Angelicae Sinensis 4---30 parts of Radix Rehmanniae 4---
Ramulus Cinnamomi 3---20 parts of 20 portions of Ganodermas 2---15 parts of Rhizoma Corydalis 3---
20 parts of Caulis Akebiaes 3---20 portions of Radix Notoginseng 3---
The Chinese medicine of this treatment coronary heart disease is made by following method:
(1) by above-mentioned weight ratio, Herba Asari, Radix Angelicae Sinensis, the Radix Rehmanniae, Ramulus Cinnamomi, Rhizoma Corydalis, Caulis Akebiae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Make Chinese medicine granules, powder, capsule, watered pill, tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910236179XA CN101843717B (en) | 2009-10-22 | 2009-10-22 | Chinese medicament for treating coronary disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910236179XA CN101843717B (en) | 2009-10-22 | 2009-10-22 | Chinese medicament for treating coronary disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101843717A CN101843717A (en) | 2010-09-29 |
| CN101843717B true CN101843717B (en) | 2011-09-28 |
Family
ID=42768653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910236179XA Expired - Fee Related CN101843717B (en) | 2009-10-22 | 2009-10-22 | Chinese medicament for treating coronary disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101843717B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102091247B (en) * | 2010-12-06 | 2012-01-11 | 熊攀 | Traditional Chinese medicine composition for treating coronary heart disease |
-
2009
- 2009-10-22 CN CN200910236179XA patent/CN101843717B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101843717A (en) | 2010-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843787A (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN101843717B (en) | Chinese medicament for treating coronary disease | |
| CN101843660B (en) | Chinese medicament for treating tachycardia | |
| CN101843712B (en) | Chinese medicament for treating angina | |
| CN101843829B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101850055B (en) | Chinese medicament for treating coronary heart diseases | |
| CN101843755A (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101843644B (en) | Chinese medicament for treating tachycardia | |
| CN101843753B (en) | Chinese medicament for treating angina | |
| CN101843878B (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101843807A (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101843758B (en) | Chinese medicament for treating coronary disease | |
| CN101843835B (en) | Chinese medicament for treating coronary diseases | |
| CN101843832B (en) | Chinese medicament for treating coronary disease | |
| CN101843831B (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101564476B (en) | Chinese medicament for treating coronary heart disease | |
| CN101849985B (en) | Chinese medicament for treating tachycardia | |
| CN101843700A (en) | Chinese medicament for treating coronary disease | |
| CN101850054B (en) | Chinese medicament for treating diabetic heart diseases | |
| CN101843793B (en) | Chinese medicament for treating tachycardia | |
| CN101843720B (en) | Chinese medicament for treating angina | |
| CN101843797A (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843679A (en) | Chinese medicament for treating cervical spondylosis | |
| CN101843730A (en) | Chinese medicament for treating coronary disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: RUGAO RICH STEEL MACHINERY PARTS CO., LTD. Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20130710 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130710 Address after: 226500, Jiangsu, Rugao moved by the town, moved through the village of twenty-four groups Patentee after: Rugao Fu Steel Machinery Fittings Co., Ltd. Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Deng Wenrong Inventor before: Liu Xinzhuang |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20171229 Address after: Dacheng County, Hebei province 065999 Langfang City Ping Shu Zhen Nan Huan Xi Lu IFAD No. 1 Building 2 unit 301 room Patentee after: Deng Wenrong Address before: 226500, Jiangsu, Rugao moved by the town, moved through the village of twenty-four groups Patentee before: Rugao Fu Steel Machinery Fittings Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110928 Termination date: 20181022 |